A medical and aesthetic clinic in Al Manara that publishes a broad peptide-therapy service page.
Availability does not establish approval or effectiveness. Ask for the exact active ingredient, product registration, indication, prescriber, dispensing source, risks, alternatives, and follow-up plan.
The clinic names multiple compounds with materially different evidence and regulatory status. Several listed uses are experimental; the clinic's marketing statements are not treated as independent clinical evidence.
Enfield Royal Clinic's English and Arabic official peptide pages display materially different price information.
We do not publish a comparison figure until the clinic resolves the discrepancy. Request an itemised written quote directly.
Price information is attributed to the clinic and may change. It does not establish medical approval, product registration, effectiveness or the total cost of care.
These labels assess the named molecule, not the clinic’s particular product, protocol or marketing claim. UAE registration remains product and indication specific.
| Peptide | Category | Evidence | Approval note | Editorial assessment |
|---|---|---|---|---|
| AOD-9604 | Experimental compound | Limited | Not established for broad weight-loss use | Early research does not establish the broad weight-management outcomes frequently used in marketing. |
| BPC-157 | Experimental compound | Preclinical | Not established as an approved human medicine | Most supportive claims rely on laboratory or animal research; robust clinical evidence and established approval are lacking. |
| CJC-1295 | Experimental compound | Limited | Not established as an approved human medicine | Small human studies do not establish broad wellness, anti-ageing or body-composition claims. |
| GHK-Cu | Experimental compound | Limited | Depends on formulation and intended use | Cosmetic ingredient use is different from injected or systemic treatment claims. Evidence and regulation depend on formulation. |
| Ipamorelin | Experimental compound | Limited | Not established as an approved human medicine | Human evidence is limited and does not establish the broad outcomes commonly promoted by clinics. |
| Semaglutide | Prescription medicine | High | Product and indication specific | Supported by substantial human evidence for specific approved metabolic indications. Verify the exact UAE-registered brand and intended use. |
| TB-500 | Experimental compound | Preclinical | Not established as an approved human medicine | Commercial claims extend beyond the available human evidence. Product identity and regulatory status require particular caution. |
10:00am–9:00pm, daily
+971 4 373 9000Compare clinical assessment, product traceability, informed consent, monitoring, adverse-event support, and alternatives—not marketing claims.
Is this information outdated? Send the editorial team a correction.Clinics cannot pay to change directory order or evidence classifications.